Immunization with Leishmania infantum released proteins confers partial protection against parasite infection with a predominant Th1 specific immune response

Vaccine

Volumn 25, Issue 23, 2007, Pages 4525-4532

  Rosa, Ricardo ^a   Marques, Cláudia ^a   Rodrigues, Olivia Roos ^a   Santos Gomes, Gabriela M ^a  

^a INSTITUTO DE HIGIENE E MEDICINA TROPICAL   (Portugal)

Author keywords

CD4+ T cells; CD8+ T cells; Immunization; Leishmania infantum released proteins; Protective immune response

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 4; PROTEIN LIRIC1; PROTEIN LIRIC2; PROTOZOAL PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BAGG ALBINO MOUSE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; IMMUNE RESPONSE; IMMUNIZATION; LEISHMANIA INFANTUM; LEISHMANIASIS; MOUSE; NONHUMAN; PARASITOSIS; PRIORITY JOURNAL; PROMASTIGOTE; PROPHYLAXIS; SPLEEN; TH1 CELL;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; IMMUNIZATION; INTERFERON TYPE II; INTERLEUKIN-12; LEISHMANIA INFANTUM; LEISHMANIASIS, VISCERAL; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; PROTOZOAN PROTEINS; SPLEEN; TH1 CELLS;

EID: 34248399629     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2007.04.003     Document Type: Article

References (28)

1. Bern C., Adler-Moore J., Berenguer J., Boelaert M., den Boer M., Davidson R.N., et al. Liposomal amphotericin B for the treatment of visceral leishmaniasis. Clin Infect Dis 43 (2006) 917-924
2. Alvar J., Molina R., San Andres M., Tesouro M., Nieto J., Vitutia M., et al. Canine leishmaniasis: clinical, parasitological and entomological follow-up after chemotherapy. Ann Trop Med Parasitol 88 (1994) 371-378
3. Denerolle P., and Bourdoiseau G. Combination allopurinol and antimony treatment versus antimony alone and allopurinol alone in the treatment of canine leishmaniasis (96 cases). J Vet Intern Med 13 (1999) 413-415
4. Ikeda-Garcia F.A., Lopes R.S., Marques F.J., de Lima V.M., Morinishi C.K., Bonello F.L., et al. Clinical and parasitological evaluation of dogs naturally infected by Leishmania (Leishmania) chagasi submitted to treatment with meglumine antimoniate. Vet. Parasitol. 143 3-4 (2007) 254-259
5. Gradoni L., Maroli M., Gramiccia M., and Mancianti F. Leishmania infantum infection rates in Phlebotomus perniciosus fed on naturally infected dogs under antimonial treatment. Med Vet Entomol 1 (1987) 339-342
6. João A., Pereira M.A., Cortes S., and Santos-Gomes G.M. Canine leishmaniasis chemotherapy: dog's clinical condition and risk of Leishmania transmission. J Vet Med Ser A 53 10 (2006) 540-545
7. Mary C., Auriault V., Faugere B., and Dessein A.J. Control of Leishmania infantum infection is associated with CD8(+) and gamma interferon- and interleukin-5-producing CD4(+) antigen-specific T cells. Infect Immun 67 11 (1999) 5559-5566
8. Tsagozis P., Karagouni E., and Dotsika E. CD8(+) T cells with parasite-specific cytotoxic activity and a Tc1 profile of cytokine and chemokine secretion develop in experimental visceral leishmaniasis. Parasite Immunol 25 11-12 (2003) 569-579
9. Gomes-Pereira S., Rodrigues O.R., Rolão N., Almeida P.D., and Santos-Gomes G.M. Hepatic cellular immune responses in mice with "cure" and "non-cure" phenotype to Leishmania infantum infection: importance of CD8+ T cells and TGF-beta production. FEMS Immunol Med Microbiol 41 1 (2004) 59-68
10. Rosa R., Marques C., Rodrigues O.R., and Santos-Gomes G.M. Leishmania infantum released proteins specifically regulate cytokine expression and production patterns by CD4+ and CD8+ T cells. Acta Tropica 97 (2006) 309-317
11. Rosa R., Rodrigues O.R., Marques C., and Santos-Gomes G.M. Leishmania infantum: soluble proteins released by the parasite exert differential effects on host immune response. Exp Parasitol 109 (2005) 106-114
12. Santos-Gomes G.M., and Abranches P. Comparative study of infectivity caused by promastigotes of Leishmania infantum MON-1, L. infantum MON-24 and L. donovani MON-18. Folia Parasitol 43 1 (1996) 7-12
13. Buffet P.A., Sulahian A., Garin Y.J., Nassar N., and Derouin F. Culture microtitration: a sensitive method for quantifying Leishmania infantum in tissues of infected mice. Antimicrob Agents Chemother 39 9 (1995) 2167-2168
14. Holaday B.J., Pompeu M.M., Jeronimo S., Texeira M.J., Sousa Ade A., Vasconcelos A.W., et al. Potential role for interleukin-10 in the immunosuppression associated with kala azar. J Clin Invest 92 (1993) 2626-2632
15. Santos-Gomes G.M., Rosa R., Leandro C., Cortes S., Romao P., and Silveira H. Cytokine expression during the outcome of canine experimental infection by Leishmania infantum. Vet Immunol Immunopathol 88 (2002) 21-30
16. Mookerjee A., Sen P.C., and Ghose A.C. Immunosuppression in hamsters with progressive visceral leishmaniasis is associated with an impairment of protein kinase C activity in their lymphocytes that can be partially reversed by okadaic acid or anti-transforming growth factor beta antibody. Infect Immun 71 (2003) 2439-2446
17. Manetti R., Parronchi P., Giudizi M.G., Piccinni M.P., Maggi E., Trinchieri G., et al. Natural killer cell stimulatory factor (interleukin 12 [IL-12]) induces T helper type 1 (Th1)-specific immune responses and inhibits the development of IL-4-producing Th cells. J Exp Med 177 4 (1993) 199-204
18. Sypek J.P., Chung C.L., Mayor S.E., Subramanyam J.M., Goldman S.J., Sieburth D.S., et al. Resolution of cutaneous leishmaniasis: interleukin-12 initiates a protective T helper type 1 immune response. J Exp Med 177 6 (1993) 1797-1802
19. O'Garra A., and Arai N. The molecular basis of T helper 1 and T helper 2 cell differentiation. Trends Cell Biol 10 12 (2000) 542-550
20. Tewary P., Saxena S., and Madhubala R. Co-administration of IL-12 DNA with rORFF antigen confers long-term protective immunity against experimental visceral leishmaniaisis. Vaccine 24 (2006) 2409-2416
21. Liew F.Y., Li Y., and Millott S. Tumor necrosis factor-α synergizes with IFN-γ in mediating killing of Leishmania major through the induction of nitric oxide. J Immunol 145 (1990) 4306-4310
22. Stobie L., Gurunathan S., Prussin C., Sacks D.L., Glaichenhaus N., Wu C.Y., et al. The role of antigen and IL-12 in sustaining Th1 memory cells in vivo: IL-12 is required to maintain memory/effector Th1 cells sufficient to mediate protection to an infectious parasite challenge. Proc Natl Acad Sci USA 97 15 (2000) 8427-8432
23. Heinzel F.P., Schoenhaut D.S., Rerko R.M., Rosser L.E., and Gately M.K. Recombinant interleukin 12 cures mice infected with Leishmania major. J Exp Med 177 5 (1993) 1505-1509
24. Mattner F., Magram J., Ferrante J., Launois P., Di Padova K., Behin R., et al. Genetically resistant mice lacking interleukin-12 are susceptible to infection with L. major and mount polarized Th2 responses. Eur J Immunol 26 (1996) 1553-1559
25. Yamakami K., Akao S., Tadakuma T., Nitta Y., Miyazaki J., and Yoshizawa N. Administration of plasmids expressing interleukin-4 and interleukin-10 causes BALB/c mice to induce a T helper 2-type response despite the expected T helper 1-type response with a low-dose infection of Leishmania major. Immunology 105 4 (2002) 515-523
26. Murray H.W., Flanders K.C., Donaldson D.D., Sypek J.P., Gotwals P.J., Liu J., et al. Antagonizing deactivating cytokines to enhance host defense and chemotherapy in experimental visceral leishmaniasis. Infect Immun 73 7 (2005) 3903-3911
27. Melby P.C., Yang Y.Z., Cheng J., and Zhao W. Regional differences in the cellular immune response to experimental cutaneous or visceral infection with Leishmania donovani. Infect Immun 66 1 (1998) 18-27
28. Gurunathan S., Stobie L., Prussin C., Sacks D.L., Glaichenhaus N., Iwasaki A., et al. Requirements for the maintenance of Th1 immunity in vivo following DNA vaccination: a potential immunoregulatory role for CD8+ T cells. J Immunol 165 2 (2000) 915-924